Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2007. Start Trial.
Date Value
October 30, 2026 0.5945
October 29, 2026 0.6539
October 28, 2026 0.6359
October 27, 2026 0.6363
October 26, 2026 0.6402
October 23, 2026 0.6228
October 22, 2026 0.6594
October 21, 2026 0.6851
October 20, 2026 0.6429
October 19, 2026 0.5978
October 16, 2026 0.6171
October 15, 2026 0.6436
October 14, 2026 0.654
October 13, 2026 0.6498
October 12, 2026 0.663
October 09, 2026 0.6683
October 08, 2026 0.6602
October 07, 2026 0.669
October 06, 2026 0.6644
October 05, 2026 0.6541
October 02, 2026 0.6954
October 01, 2026 0.6851
September 30, 2026 0.6633
September 29, 2026 0.7578
September 28, 2026 0.7888
Date Value
September 25, 2026 0.7935
September 24, 2026 0.7783
September 23, 2026 0.8073
September 22, 2026 0.8199
September 21, 2026 0.7681
September 18, 2026 0.7785
September 17, 2026 0.7569
September 16, 2026 0.7578
September 15, 2026 0.7682
September 14, 2026 0.7703
September 11, 2026 0.7402
September 10, 2026 0.7561
September 09, 2026 0.7889
September 08, 2026 0.7889
September 04, 2026 0.8097
September 03, 2026 0.7694
September 02, 2026 0.8138
September 01, 2026 0.7785
August 31, 2026 0.8097
August 28, 2026 0.8022
August 27, 2026 0.7631
August 26, 2026 0.7682
August 25, 2026 0.7941
August 24, 2026 0.8097
August 21, 2026 0.8512

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Trulieve Cannabis Corp. 2.577
cbdMD, Inc. 0.5182
ANI Pharmaceuticals, Inc. 2.770
Corcept Therapeutics, Inc. 12.40
Veru, Inc. 1.316

Price to Book Value Related Metrics

PS Ratio 0.3413
PEG Ratio -0.0158
Price to Free Cash Flow 48.28
Price 0.5727
Earnings Yield -50.92%
Market Cap 213.24M
PEGY Ratio -0.0158
Operating PE Ratio 2.547